Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas HER2 and HER3 Are Predictors of Poor OutcomeMaria D Begnami Emy Fukuda; José H. T. G Fregnani; Suely Nonogaki; André L Montagnini; Wilson L. da Costa Júnior; Fernando Augusto SoaresJournal of Clinical Oncology New York v. 29, n. 22, p. 3030-3036, Aug., 2011New York 2011Item não circula. Consulte sua biblioteca.(Acessar) |
2 |
Material Type: Artigo
|
![]() |
Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas HER2 and HER3 Are Predictors of Poor OutcomeMaria D Begnami Emy Fukuda; José H. T. G Fregnani; Suely Nonogaki; André L Montagnini; Wilson L. da Costa Júnior; Fernando Augusto SoaresJournal of Clinical Oncology New York v. 29, n. 22, p. 3030-3036, Aug., 2011New York 2011Item não circula. Consulte sua biblioteca.(Acessar) |
3 |
Material Type: Artigo
|
![]() |
A quantitative analysis of association between protocol deviation and adverse event in multicenter clinical trials for cancer (JCOG0704 A)Sato, A. ; Yoshimura, K. ; Saito, I. ; Nakamura, K. ; Fukuda, H.Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.6585-6585 [Periódico revisado por pares]Texto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Exploratory analysis to seek for the optimal definition of progression-free survival (PFS) in preoperative cancer therapy: Using phase III trials of Japan Clinical Oncology Group (JCOG)Nakamura, K. ; Shibata, T. ; Saito, I. ; Fukuda, H.Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.6604-6604 [Periódico revisado por pares]Texto completo disponível |
5 |
Material Type: Artigo
|
![]() |
A phase II trial of combined treatment of endoscopic mucosal resection (EMR) and chemoradiotherapy (CRT) for clinical stage I esophageal squamous cell carcinoma (ESCC): Japan Clinical Oncology Group study JCOG0508Tsuchida, T. ; Muto, M. ; Minashi, K. ; Ono, H. ; Morita, Y. ; Ishihara, R. ; Toshiro, I. ; Kawai, H. ; Boku, N. ; Fukuda, H.Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.TPS204-TPS204 [Periódico revisado por pares]Texto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Time to publication of the results of clinical trials conducted by Japan Clinical Oncology Group (JCOG)Katayama, H. ; Nakamura, K. ; Mizusawa, J. ; Takashima, A. ; Kunieda, F. ; Kanato, K. ; Matsubara, S. ; Kimura, A. ; Shibata, T. ; Saito, I. ; Fukuda, H.Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e16640-e16640 [Periódico revisado por pares]Texto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Comparison of the modality type in trials conducted by multicenter cancer cooperative groups between Japan and the United StatesKunieda, F. ; Nakamura, K. ; Shibata, T. ; Katayama, H. ; Mizusawa, J. ; Kanato, K. ; Matsubara, S. ; Takashima, A. ; Kimura, A. ; Saito, I. ; Fukuda, H.Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e16554-e16554 [Periódico revisado por pares]Texto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Development time of trial protocols in the Japan Clinical Oncology Group (JCOG)Kimura, A. ; Nakamura, K. ; Shibata, T. ; Mizusawa, J. ; Saito, I. ; Takashima, A. ; Katayama, H. ; Kunieda, F. ; Kanato, K. ; Matsubara, S. ; Fukuda, H.Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e16568-e16568 [Periódico revisado por pares]Texto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Randomized phase II study of best-available 5-fluorouracil (5-FU) versus weekly paclitaxel in gastric cancer (GC) with peritoneal metastasis (PM) refractory to 5-FU-containing regimens (JCOG0407)Takiuchi, H. ; Fukuda, H. ; Boku, N. ; Shimada, Y. ; Nasu, J. ; Hamamoto, Y. ; Hironaka, S. ; Yamaguchi, K. ; Takashima, A. ; Ohtsu, A.Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4052-4052 [Periódico revisado por pares]Texto completo disponível |
10 |
Material Type: Artigo
|
![]() |
A multicenter randomized phase II (rPII)/III study comparing concurrent chemoradiotherapy (CRT) with low-dose cisplatin plus continuous infusion of 5-fluorouracil (LDPF) and standard-dose PF (SDPF) for locally advanced unresectable squamous cell carcinoma of the thoracic esophagus (JCOG0303)Shinoda, M. ; Ando, N. ; Kato, H. ; Tsubosa, Y. ; Minashi, K. ; Watanabe, G. ; Ikeda, K. ; Kawano, T. ; Nakamura, K. ; Fukuda, H.Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4053-4053 [Periódico revisado por pares]Texto completo disponível |